MK-1484
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-1484, covering 2024-11-14 to 2024-11-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) [Phase 1]